RIGEL PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
RIGEL PHARMACEUTICALS, INC. (RIGL) had Accumulated Other Comprehensive Income of -$148.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$148.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$128.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $181.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $96.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$148.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$128.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $181.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $96.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $6.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$2.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $10.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $11.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$9.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$5.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $8.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | -$15.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$25.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | -$27.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | -$153.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$286.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$438.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | -$416.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | -$102.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $8.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $7.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | -$1.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$4.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $46.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $78.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $23.00K 10-K · filed 2021-03-02 |
| 2019-09-30 | $36.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $43.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$24.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | -$25.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$49.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$87.00K 10-Q · filed 2018-05-01 |
| 2017-12-31 | -$82.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | -$7.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$19.00K 10-Q · filed 2017-08-01 |
| 2017-03-31 | -$29.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | -$18.00K 10-K · filed 2018-03-06 |
| 2016-09-30 | $9.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $53.00K 10-Q · filed 2016-08-02 |
| 2016-03-31 | $49.00K 10-Q · filed 2016-05-03 |
| 2015-12-31 | -$44.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $25.00K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $11.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $17.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$7.00K 10-K · filed 2016-03-08 |
| 2014-09-30 | $16.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $42.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $38.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $47.00K 10-K · filed 2015-03-03 |
| 2013-09-30 | $129.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $17.00K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $78.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $82.00K 10-K · filed 2014-03-04 |
| 2012-09-30 | $106.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $37.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $25.00K 10-Q · filed 2012-05-01 |
| 2011-12-31 | $6.00K 10-K · filed 2013-03-05 |
| 2011-09-30 | -$22.00K 10-Q · filed 2011-11-01 |
| 2011-06-30 | $60.00K 10-Q · filed 2011-08-02 |
| 2010-12-31 | -$38.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |